text
Efficacy of a Covalent ERK1/2 Inhibitor, CC-90003, in KRAS Mutant Cancer Models Reveals Novel Mechanisms of Response and Resistance
Authors Ida Aronchik1, Yumin Dai1, Matt Labenski2, Carmen Barnes2, Terri Jones2, Lixin QIao2, Lisa Beebe2,...